Menu
Home
Conferences
Collections
Calls for Papers
MSF Research Ethics
About
My Saved Content
Science Portal
Advanced Search
My Saved Content
Browse All
Conferences
Collections
Calls for Papers
MSF Research Ethics
Clinical Case Reporting
About
English
Conference Material
|
Video
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
Mansoor H,
Hirani N,
Chavan VV,
Joshi A,
Oswal V,
Sharma J,
Iyer AS,
England K,
Ndlovu Z,
Silsarma A,
Isaakidis P,
Morales M
Save
Cite
Share
Save
Cite
Share
Similar Content
Slide Presentation
|
Slide Presentation
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Abstract
|
Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Loading...
Countries
India
Subject Area
antibiotic resistance
tuberculosis
diagnostics
genetics & genomics
antimicrobial resistance
Languages
English
DOI
10.57740/3gdn-kn91
Published Date
07 Jun 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|
Slide Presentation
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Conference Material
|
Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India | Conference Material / Video | MSF Science Portal
